chr12-93850180-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 4P and 1B. PM2PP5_ModerateBP4
The NM_003805.5(CRADD):c.509G>A(p.Arg170His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000274 in 1,613,712 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Genomes: 𝑓 0.00049 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00025 ( 0 hom. )
Consequence
CRADD
NM_003805.5 missense
NM_003805.5 missense
Scores
1
7
11
Clinical Significance
Conservation
PhyloP100: 2.25
Genes affected
CRADD (HGNC:2340): (CASP2 and RIPK1 domain containing adaptor with death domain) This gene encodes a protein containing a death domain (DD) motif. This protein recruits caspase 2/ICH1 to the cell death signal transduction complex, which includes tumor necrosis factor receptor 1 (TNFR1A) and RIPK1/RIP kinase, and acts in promoting apoptosis. A mutation in this gene was associated with cognitive disability. A related pseudogene is found on chromosome 3. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 12-93850180-G-A is Pathogenic according to our data. Variant chr12-93850180-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 372191.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr12-93850180-G-A is described in Lovd as [Pathogenic]. Variant chr12-93850180-G-A is described in Lovd as [Likely_pathogenic].
BP4
Computational evidence support a benign effect (MetaRNN=0.009552389). . Strength limited to SUPPORTING due to the PP5.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CRADD | NM_003805.5 | c.509G>A | p.Arg170His | missense_variant | 3/3 | ENST00000332896.8 | NP_003796.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CRADD | ENST00000332896.8 | c.509G>A | p.Arg170His | missense_variant | 3/3 | 1 | NM_003805.5 | ENSP00000327647.3 |
Frequencies
GnomAD3 genomes AF: 0.000493 AC: 75AN: 152180Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
75
AN:
152180
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000579 AC: 145AN: 250448Hom.: 0 AF XY: 0.000516 AC XY: 70AN XY: 135598
GnomAD3 exomes
AF:
AC:
145
AN:
250448
Hom.:
AF XY:
AC XY:
70
AN XY:
135598
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000251 AC: 367AN: 1461414Hom.: 0 Cov.: 32 AF XY: 0.000234 AC XY: 170AN XY: 726958
GnomAD4 exome
AF:
AC:
367
AN:
1461414
Hom.:
Cov.:
32
AF XY:
AC XY:
170
AN XY:
726958
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000492 AC: 75AN: 152298Hom.: 0 Cov.: 32 AF XY: 0.000752 AC XY: 56AN XY: 74488
GnomAD4 genome
AF:
AC:
75
AN:
152298
Hom.:
Cov.:
32
AF XY:
AC XY:
56
AN XY:
74488
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
63
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Intellectual disability, autosomal recessive 34 Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Feb 17, 2023 | - - |
Likely pathogenic, no assertion criteria provided | curation | Reproductive Health Research and Development, BGI Genomics | Jan 06, 2020 | NM_003805.3:c.509G>A in the CRADD gene has an allele frequency of 0.006 in European (Finnish) subpopulation in the gnomAD database. Functional studies demonstrate that Arg107Cys failed to induce cell death (PMID:27773430). Pathogenic computational verdict because pathogenic predictions from DANN, DEOGEN2, EIGEN, FATHMM-MKL, M-CAP, MutationAssessor, MutationTaster, REVEL and SIFT. The patient's phenotype is highly specific for CRADD gene(PMID: 27773430). Taken together, we interprete this variant as Pathogenic/Likely pathogenic. ACMG/AMP criteria applied: PS3; PP3; PP4. - |
Intellectual disability Pathogenic:1
Pathogenic, criteria provided, single submitter | research | Center for Statistical Genetics, Columbia University | Oct 16, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Pathogenic
DEOGEN2
Uncertain
D;D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;T
M_CAP
Benign
D
MetaRNN
Benign
T;T
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M;M
PrimateAI
Benign
T
PROVEAN
Benign
N;N
REVEL
Uncertain
Sift
Benign
D;D
Sift4G
Benign
T;T
Polyphen
D;D
Vest4
MVP
MPC
0.45
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at